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Background and purpose   Tantalum rod implantation has recently 
been proposed for treatment of early stages of femoral head osteo-
necrosis. The purpose of our study was to report the early results 
of its use in pre- and post-collapse stages of the disease. 
Methods   We studied prospectively 27 patients who underwent 
tantalum rod implantation for treatment of nontraumatic femo-
ral head osteonecrosis between December 2000 and September 
2005. Patients were evaluated radiologically and clinically using 
the Steinberg classification and the Harris hip score (HHS). Dis-
ease stage varied between stages II and IV. Mean follow-up time 
was 38 (15–71) months.
Results   1 patient (1 hip) died 15 months after surgery for rea-
sons unrelated to it. 13 of 26 hips remained at the same radio-
graphic stage, and 13 deteriorated. Mean HHS improved from 
49 to 85. 6 patients required conversion to total hip arthroplasty. 
When the procedure was used for stages III and IV, both radio-
logical outcome and revision rates were worse than for the stage 
II hips. There was, however, no difference in postoperative HHS 
between patients at pre- and post-collapse stages at the time of 
initial evaluation. Survivorship, with revision to THA as the end-
point, was 70% at 6 years.
Interpretation   The disease process does not appear to be inter-
rupted, but there was a significant improvement in hip function 
initially in most hips. Tantalum rod implantation is a safe “buy-
time” technique, especially when other joint salvage procedures 
are not an option. Appropriate patient selection and careful rod 
insertion are needed for favorable results.   

 
The femoral head is the most vulnerable site for develop-
ment  of  osteonecrosis.  The  incidence  is  increasing:  every 
year 10,000–20,000 new cases are diagnosed in the USA and 
5–12% of total hip arthroplasties performed each year are due 
to osteonecrosis (Mont and Hungerford 1995). Although early 
diagnosis has been facilitated by the use of bone scan and 
MRI, there is no universally accepted treatment—especially 
at the early stage of disease.
 The joint-preserving procedures include core decompres-
sion with or without bone grafting (Camp and Colwell 1986, 
Steinberg et al. 2001), rotational osteotomy (Sugioka et al. 
1982), varus or valgus osteotomy (Dresher et al. 2003), non-
vascularized fibula grafting (Plakseychuk et al. 2003), vas-
cularized fibula grafting (Malizos et al. 1995, Urbaniak et al. 
1995, Sotereanos et al. 1997, Plakseychuk et al. 2001), and—
recently—implantation of trabecular metal tantalum rod with 
3 reports (Tsao et al. 2005, Veillette et al. 2006, Shuler et al. 
2007). We evaluated the clinical and radiological outcome fol-
lowing implantation of a porous tantalum implant for treat-
ment of pre- and post-collapse stages of nontraumatic femoral 
head osteonecrosis.
Patients and methods
We studied prospectively 27 patients (32 hips) who underwent 
tantalum rod implantation for treatment of nontraumatic femo-
ral head osteonecrosis between December 2000 and September 
2005. Although the preferred joint-preserving procedure at our 
institution is vascularized fibular graft, we proposed tantalum 
rod to patients who were medically unfit or unwilling to undergo 
this  longer  procedure  with  long  rehabilitation,  or  to  young 
patients with post-collapse disease who were reluctant to have 
a total hip replacement. The study was approved by the ethics 
committee of our institution (date of issue 1/11/2000, registra-
tion no. 035) and all patients gave their informed consent.
The study included 23 male and 4 female patients with a 
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months postoperatively for reasons unrelated to surgery (sickle 
cell crisis), and was excluded from the study. Osteonecrosis 
was idiopathic in 8 patients, secondary to cortisone intake in 
15, due to alcohol intake in 2, and secondary to sickle cell 
anemia in 1 patient. None of the patients had any prior treat-
ment for the osteonecrosis. The preoperative stage was stage II 
in 9 patients, stage III in 7, and stage IV in 10 patients. Mean 
follow-up was 38 (15–71) months. No patients were lost to 
follow-up. 
5 patients had bilateral tantalum rod implantation. For these 
5 patients, 1 of the hips was selected using a computer-gener-
ated random sequence in order to fulfill the requirement of 
data independence for statistical analysis purposes.
 Patients were evaluated preoperatively and at the end of the 
follow-up period, both clinically and radiologically using the 
Harris hip score (HHS) and Steinberg classification (Harris 
1969, Steinberg et al. 1995). The mean preoperative HHS was 
49 (SD 19). All patients underwent preoperative radiography 
and MR imaging of the hips. Postoperative Steinberg stage 
evaluation was based on plain radiographs. 
Two independent observers other than the surgeons did the 
radiographic evaluation. In cases of discordance, a unanimous 
final judgment was made. We made no attempt to examine 
the intraobserver or interobserver variability. Throughout the 
study, clinical evaluation was done by a single observer (not 
a surgeon). 
Finally, an MRI-based volumetric method was used to quan-
tify the size of the lesion on the preoperative MRI scans. We 
used a semi-automated technique in which the area with abnor-
mal signal was outlined for each MRI slice using the tracing 
tool of the ANALYZE image analysis software, version 8.1 
(Mayo Foundation, Rochester, MN). We have reported details 
of the technique elsewhere (Malizos et al. 2001).
The implant used was a porous tantalum rod (10 mm in 
diameter) (Trabecular Metal; Zimmer Trabecular Metal Tech-
nology, Allendale, NJ). It was inserted through a small lat-
eral incision under biplanar fluoroscopic guidance, and it was 
aimed at the osteonecrotic lesion to support the subchondral 
bone. The tip of the rod was advanced not more than 5 mm 
from the articular surface. We did not place any bone graft in 
the femoral head. Although according to the technique origi-
nally described the lateral part of the rod should abut the lat-
eral femoral cortex, we used shorter rods (either 70 or 75 mm) 
so that the rod ended distally at the cancellous bone of the 
trochanteric area. With this method, if a later arthroplasty is 
required, the initial cortical defect will have been filled with 
bone. The distal threads and the high frictional stability of the 
implant prevent backing out.
There were no perioperative complications. Postoperative 
rehabilitation included partial weight bearing for 6 weeks. 
Statistics
We used the Wilcoxon signed ranks test to compare the dif-
ferences in pre- and postoperative Steinberg classification and 
HHS. The Wilcoxon-Mann-Whitney test was used to compare 
postoperative Steinberg and HHS scores between primary and 
secondary etiology groups. 95% bootstrap confidence inter-
vals (CIs) for differences in median values follow p-values 
were  calculated  using  the  Wilcoxon-Mann-Whitney  test. 
Spearman’s rho (ρ) was calculated for the assessment of the 
correlation of age to postoperative Steinberg and HHS scores 
and to assess the correlation between lesion size and outcome. 
The endpoint for the survival analysis was hip arthroplasty and 
the results were presented with a Kaplan-Meier survivorship 
curve. The standard error of the cumulative survival was cal-
culated using Greenwood’s formula. All reported p-values are 
two-tailed with p < 0.05 being considered significant. Analyses 
were conducted using SPSS version 15.0 (SPSS Inc., Chicago, 
IL) and S-plus version 8.0 (Insightful Corp., Seattle, WA).
Results
13 of the 26 hips did not have any radiographic progression 
of the disease at the end of the follow-up. The preoperative 
Steinberg staging of these 13 hips was: 5 stage II (Figure 2), 
2 stage III, and 6 stage IV. Of the 13 hips with radiographic 
deterioration, 4 were stage II, 5 were stage III, and 4 were 
stage IV preoperatively.
There was better radiological outcome for patients at precol-
lapse stage at the time of operation (4 of 9 stage II hips dete-
riorated) when compared to those at post-collapse stages (9 of 
17 stage III and IV hips deteriorated) (p = 0.02). Interestingly, 
there was no statistically significant difference in postoperative 
HHS between these two groups of patients (p = 0.7, 95% boot-
strap CI for median differences (–23, 19)). Moreover, HHS at 
last follow-up was not statistically significantly greater (mean 
Figure 1. Kaplan-Meier survivorship curve with 95% pointwise confi-
dence intervals using total hip arthroplasty as the endpoint. Vertical 
marks indicate censored data. 
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HHS 90, SD 13) in patients with unchanged Steinberg stage, 
when compared to those with radiographic progression (mean 
HHS 79, SD 15) (p = 0.1, 95% bootstrap CI for median differ-
ences (–2, 33)) (Figure 3).
There  were  no  significant  differences  in  the  radiological 
outcome (p = 0.3, 95% bootstrap CI for median differences 
(–2, 1)) and the clinical outcome (p = 1.0, 95% bootstrap CI 
for median differences (–20, 19.5)) between the subgroup of 
patients with a serious underlying disease (e.g. blood malig-
nancy,  lupus  erythematosus,  transplant  patients)  and  those 
without. Furthermore, we could not find any significant dif-
ference in the postoperative Steinberg stage (p = 1.0, 95% 
bootstrap CI for median differences (–1, 1)) and HHS (p = 
0.4, 95% bootstrap CI for median differences (–31, 17)) when 
we compared the primary and the secondary etiology groups 
of patients.
 There was no significant correlation between age and post-
operative Steinberg (correlation coefficient, r = 0.17) or HHS 
score (r = –0.15).
It  is  notable  that  when  all  hips  were  grouped  together, 
despite radiological deterioration over time (p < 0.001, 95% 
bootstrap  CI  for  median  differences  (–2,  –1))  there  was  a 
clinical  improvement  compared  to  the  preoperative  status 
of the patients (p < 0.001, 95% bootstrap CI for median dif-
ferences (24, 52)). The mean HHS increased from 49 (SD 
19) preoperatively to 85 (SD 15) postoperatively. The mean 
estimated survival time of the implant was 59 months (SE 4 
months, 95% CI: 50–67 months). There were no cases of tan-
talum rod breakage, loosening, or subsidence.
We  found  a  statistically  significant  positive  correlation 
between the preoperative volume of the osteonecrotic lesion 
and the postoperative radiographic stage of the disease (ρ = 
0.73). This correlation was noted not only in hips that had 
been treated prior to femoral head collapse (ρ = 0.89) but also 
in the post-collapse group of hips (ρ = 0.66). There was no 
correlation between the preoperative volume of necrotic fem-
oral head and postoperative HHS (ρ = –0.41).
During the study period, 6 of the 26 hips underwent revision 
to a total hip arthroplasty at an average of 29 months (range 
14–41 months, SD 9.2). Only 1 of the 6 hips was stage II at 
the time of the index operation (Figure 4); the others were 
stage III and IV. Overall survival was 70% (CI: 52–95) at 71 
months. All revisions were done for pain relief. There were 
no intraoperative complications during the revision procedure. 
The tantalum implant was removed uneventfully in all 6 hips: 
the cortex of the femoral neck was cut circumferentially at 
the desired level with a reciprocating saw until the rod was 
encountered. The head was then removed in a piecemeal fash-
ion by performing osteotomies at a plane tangential to the rod. 
Multiple drill holes were then made at the circumference of 
the rod, and finally the implant was removed using some back-
and-forth movements. The additional operative time that was 
required was 5–10 min. In all 6 patients, an uncemented stem 
was implanted without any intraoperative complications. This 
method did not render the femoral neck vulnerable to fracture. 
We believe that even with cemented prostheses, removal of 
the rod would not be troublesome as the entrance point of the 
rod would have healed adequately enough in order to prevent 
outflow of the cement.
 
Discussion
Preservation of an osteonecrotic femoral head depends on pre-
vention of collapse of the structurally compromised necrotic 
bone. Non-surgical management with partial weight bearing 
Figure 4. 27-year-old man with osteonecrosis secondary to cortisone 
intake for Hodgkin lymphoma. A. Preoperatively, the disease was clas-
sified as Steinberg stage II. B. 3 years later, the hip had deteriorated 
radiographically to Steinberg stage VI and required revision to THA.
Figure 3. Right hip of a 38-year-old man with idiopathic osteonecrosis. 
A. Preoperatively, Steinberg stage IV with HHS of 63. B. 3.5 years later, 
Steinberg stage remained unchanged and HHS was 93.
Figure 2. Right hip of a 15-year-old girl with osteonecrosis of the fem-
oral head secondary to cortisone intake for marrow transplantation. 
A. Preoperatively, Steinberg stage II with HHS of 85. B. 5 years later, 
radiographic Steinberg staging remained unchanged and HHS was 
100.
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can only be selected for early stages and very small lesions. 
Even in such cases, it has been proven to be ineffective in 
80–90% of patients (Mont et al. 1996, Hungerford and Mont 
1998). Other nonoperative treatment options include hyper-
baric  oxygen  (Reis  et  al.  2003),  administration  of  biphos-
phonates (Bowers et al. 2004, Lai et al. 2005), lipid-lower-
ing agents (Pritchett 2001), prostaglandin analogs (Disch et 
al. 2005), low-molecular-weight heparin (Glueck et al. 2005), 
and high-energy shock waves (Ludwig et al. 2001).
A meta-analysis of studies with core decompression or non-
operative treatment (Castro and Barrack 2000) demonstrated 
success rates (defined as no further surgical intervention) of 
61%,  59%,  and  25%  for  nonoperative  treatment  of  osteo-
necrosis of Steinberg stages I, II and III, respectively. Core 
decompression, one of the least invasive surgical procedures, 
may be efficacious in early stages and small-size lesions of 
osteonecrosis, although concerns have been raised because of 
its potential to weaken the cancellous bone within and adja-
cent to the necrotic area (Scully et al. 1998, Lavernia and 
Sierra 2000). Finite-element models have demonstrated that 
core drilling of a lesion could have major implications for the 
structural integrity of the head (Brown et al. 1993). On the 
other hand, core decompression that was originally performed 
as a diagnostic procedure has been advocated as a technique 
capable of interrupting the disease process when performed 
before subchondral collapse. A meta-analysis that evaluated 
studies with core decompression technique or nonoperative 
treatment for femoral head osteonecrosis (Castro and Barrack 
2000) found that further surgical intervention was necessary 
in 16%, 37%, and 71% of cases after core decompression of 
osteonecrosis at Steinberg stages I, II, and III, respectively. 
Radiographic  progression  after  core  decompression  has 
been well documented in the literature. In a 2–6-year follow-
up study, Smith et al. (1995) found a rate of 41%, 66%, 96%, 
and  100%  of  radiographic  deterioration  after  core  decom-
pression for Steinberg stages I, II, III, and IV, respectively. 
Similarly, Fairbank et al. (1995) reported rates of 16%, 58%, 
and 90% radiographic progression for Steinberg stages I, II, 
and III–IV, respectively. Two other studies found, in the short 
(early) term, a radiographic progression after core decompres-
sion in three-quarters of cases (Stulberg et al. 1991, Koo et al. 
1995). The best results with this procedure can be expected 
with segmental lesions (intact lateral pillar), prior to collapse 
and with radiographic signs of sclerotic bone (Mont et al. 
1998). In our series radiographic deterioration was observed 
in 4 of 9 stage II hips and in 9 of 17 stage III and IV hips, 
which compares favorably with the results of the above stud-
ies. This suggests that the benefit obtained after tantalum rod 
implantation cannot be attributed solely to the core decom-
pression effect.
Cortical bone grafting of the femoral head may offer struc-
tural reinforcement, particularly if the graft penetrates deeply 
into the superior-central or lateral aspect of the lesion (Penix 
et al. 1983). Supporting the articular surface with nonvascu-
larized fibula grafting has not provided satisfactory long-term 
results.  In  a  comparative  study,  Plakseychuk  et  al.  (2003) 
reported only one-third good and excellent results with the use 
of  nonvascularized  fibula  whereas  they  reported  two-thirds 
good and excellent results with a vascularized fibula graft. 
Even with this demanding technique, outcomes seem to be 
compromised with time, leading to a hip arthroplasty in many 
patients (Malizos et al. 1995, Xenakis et al. 1997, Malizos et 
al. 2004, Shuler et al. 2007).
Recently, trabecular metal rods implanted in the femoral 
head with or without the addition of autologous growth fac-
tors have been advocated as an alternative to prevent collapse 
in stages I–III. Because of the surface characteristics of these 
metal implants (pore dimensions and 3D structure similar to 
the cellular structure of bone), high-volume bone ingrowth is 
encouraged and collapse is prevented. The porous tantalum is 
a highly biocompatible material with a porosity of 75% and 
pore size of 430 µm. Pores are fully interconnected and the 
microtexture  of  the  material  (dodecahedron)  permits  rapid 
bony ingrowth. Elastic modulus falls between that of cortical 
and subchondral bone and compressive strength is between 
that of cortical and cancellus bone. Initial stability at implanta-
tion is high due to its high coefficient of friction. 
The use of tantalum rods for the treatment of femoral head 
osteonecrosis  was  first  proposed  in  1997  (Pedersen  et  al. 
1997). The investigators used an MR-based 3D finite element 
model of femoral head osteonecrosis to study the mechanical 
effects of a porous tantalum rod in the necrotic femoral head, 
and they concluded that the porous tantalum rod constitutes a 
reasonable mechanical substitute for a fibular graft as it effec-
tively reduces peak stress-strain ratio. Heiner et al. (1998) 
found that mean flexural stiffness was 12 Nm2 for the porous 
tantalum, whereas the fibular graft had a flexural stiffness that 
ranged from 11 to 17 Nm2. In another laboratory study, Heiner 
et al. (2001) demonstrated that the porous tantalum implant 
can effectively support the subchondral bone of the femoral 
head and that the strength of the implant is more than 9 times 
greater than the loading stress exerted on the implant.
Since then, very few clinical studies have been published. 
Tsao et al. (2005) evaluated the porous tantalum implant in a 
multicenter study that included 113 hips in 98 patients. At 4-
year follow-up, the survival rate for preoperative stage II hips 
was 70% (with revision to THA as endpoint) and the average 
HHS was 83. Best results were obtained in patients in whom 
steroid intake was the underlying factor for osteonecrosis. In 
another study (Shuler et al. 2007), tantalum rod was compared 
to free vascularized fibula graft for treatment of early-stage 
femoral head osteonecrosis (Steinberg I and II). The survival 
rate was 86% at a mean of 3 years, and it was superior to sur-
vival in patients treated with free vascularized fibula grafting. 
Information on whether or not there was radiographic progres-
sion was not given in these two studies. Veillette et al. (2006) 
studied retrospectively 58 hips after tantalum rod implanta-
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average follow-up was 2 (0.5–4.5) years. Radiographic pro-
gression was present in 16 hips. The 4-year overall survival 
was 68% (with revision to THA as endpoint). In our study, 
we also used porous tantalum rods for patients with stage III 
and IV lesions—especially in patients with serious underly-
ing medical problems. Despite that, we found survival rates 
(70% at 4 years) that are similar to those reported by Tsao 
et al. (70% at 4 years) and Veillette et al. (68% at 4 years). 
Radiographic  progression  and  revision  to  hip  arthroplasty 
were more common in patients at the post-collapse stage at 
the time of the index procedure.
Despite the radiographic deterioration that was seen in 13 
of 26 hips, HHS improved. We found no significant difference 
in postoperative HHS between patients at pre- and post-col-
lapse stages at the time of the initial evaluation. Moreover, 
postoperative HHS was similar in the group of patients with 
radiographically stable lesions over the course of the study 
and those with radiographic deterioration. There was a corre-
lation between the volume of the lesion and the postoperative 
Steinberg stage, but not between volume and the final clinical 
score.
The frequency of radiologic progression observed in our 
study  was  less  than  that  reported  for  core  decompression 
alone. This indicates that the tantalum rod implant provides 
a meaningful structural support for the subchondral plate in 
addition to the core decompression achieved by the porous 
nature of the material. 
We did not find any correlation between disease etiology 
and postoperative clinical and radiological scores (p = 0.42 
and p = 0.97, respectively). This contrasts with a recent study 
(Veillette  et  al.  2006)  in  which  higher  survival  rates  were 
found in patients without chronic systemic diseases. The two 
studies cannot be directly compared, however, as tantalum rod 
was used for postcollapse stages of osteonecrosis as well.
In summary, we found that use of the porous tantalum rod 
is a relatively easy, minimally invasive, and reproducible pro-
cedure that can provide, at least in the short term, satisfactory 
functional improvement at both pre- and post-collapse stages 
of hip osteonecrosis. To a lesser extent, it can preserve the 
structural integrity of the femoral head. This is best achieved 
in hips at the pre-collapse stage. 
It would be interesting for future studies to do randomized 
comparisons between the outcomes of tantalum rod implanta-
tion and core decompression alone, or with implantation of 
fibular strut allograft.
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